vs
Side-by-side financial comparison of Dexcom (DXCM) and Global Business Travel Group, Inc. (GBTG). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $792.0M, roughly 1.6× Global Business Travel Group, Inc.). Dexcom runs the higher net margin — 21.2% vs 10.5%, a 10.7% gap on every dollar of revenue. On growth, Global Business Travel Group, Inc. posted the faster year-over-year revenue change (34.0% vs 21.6%). Over the past eight quarters, Global Business Travel Group, Inc.'s revenue compounded faster (13.9% CAGR vs 12.0%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
A travel management company (TMC) is a travel agency which manages organizations' corporate or business travel programs. Such companies will often provide an end-user online booking tool, mobile application, program management, and consulting teams, executive travel services, meetings and events support, reporting functionality, duty of care, and more. Non-Profit travel management companies also provide services to manage complex visa requirements, pre-trip medical needs, remote area travel, ...
DXCM vs GBTG — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $792.0M |
| Net Profit | $267.3M | $83.0M |
| Gross Margin | 62.9% | — |
| Operating Margin | 25.6% | 3.7% |
| Net Margin | 21.2% | 10.5% |
| Revenue YoY | 21.6% | 34.0% |
| Net Profit YoY | 153.6% | 692.9% |
| EPS (diluted) | $0.67 | $0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $792.0M | ||
| Q3 25 | $1.2B | $674.0M | ||
| Q2 25 | $1.2B | $631.0M | ||
| Q1 25 | $1.0B | $621.0M | ||
| Q4 24 | $1.1B | $591.0M | ||
| Q3 24 | $994.2M | $597.0M | ||
| Q2 24 | $1.0B | $625.0M |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $83.0M | ||
| Q3 25 | $283.8M | $-62.0M | ||
| Q2 25 | $179.8M | $15.0M | ||
| Q1 25 | $105.4M | $75.0M | ||
| Q4 24 | $151.7M | $-14.0M | ||
| Q3 24 | $134.6M | $-128.0M | ||
| Q2 24 | $143.5M | $27.0M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 3.7% | ||
| Q3 25 | 20.1% | 1.8% | ||
| Q2 25 | 18.4% | 5.4% | ||
| Q1 25 | 12.9% | 8.9% | ||
| Q4 24 | 17.0% | 5.1% | ||
| Q3 24 | 15.3% | 4.5% | ||
| Q2 24 | 15.7% | 6.7% |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 10.5% | ||
| Q3 25 | 23.5% | -9.2% | ||
| Q2 25 | 15.5% | 2.4% | ||
| Q1 25 | 10.2% | 12.1% | ||
| Q4 24 | 13.6% | -2.4% | ||
| Q3 24 | 13.5% | -21.4% | ||
| Q2 24 | 14.3% | 4.3% |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $0.16 | ||
| Q3 25 | $0.70 | $-0.13 | ||
| Q2 25 | $0.45 | $0.03 | ||
| Q1 25 | $0.27 | $0.16 | ||
| Q4 24 | $0.37 | $-0.04 | ||
| Q3 24 | $0.34 | $-0.28 | ||
| Q2 24 | $0.35 | $0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $434.0M |
| Total DebtLower is stronger | — | $1.4B |
| Stockholders' EquityBook value | $2.7B | $1.6B |
| Total Assets | $6.3B | $4.9B |
| Debt / EquityLower = less leverage | — | 0.88× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $434.0M | ||
| Q3 25 | $1.8B | $427.0M | ||
| Q2 25 | $1.2B | $601.0M | ||
| Q1 25 | $904.9M | $552.0M | ||
| Q4 24 | $606.1M | $536.0M | ||
| Q3 24 | $621.2M | $524.0M | ||
| Q2 24 | $939.2M | $515.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | — | — |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $1.6B | ||
| Q3 25 | $2.7B | $1.5B | ||
| Q2 25 | $2.6B | $1.2B | ||
| Q1 25 | $2.3B | $1.1B | ||
| Q4 24 | $2.1B | $1.1B | ||
| Q3 24 | $2.0B | $1.1B | ||
| Q2 24 | $2.4B | $1.2B |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $4.9B | ||
| Q3 25 | $7.5B | $4.8B | ||
| Q2 25 | $7.3B | $3.9B | ||
| Q1 25 | $6.8B | $3.8B | ||
| Q4 24 | $6.5B | $3.6B | ||
| Q3 24 | $6.4B | $3.8B | ||
| Q2 24 | $6.8B | $3.8B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.88× | ||
| Q3 25 | — | 0.91× | ||
| Q2 25 | — | 1.15× | ||
| Q1 25 | — | 1.23× | ||
| Q4 24 | — | 1.32× | ||
| Q3 24 | — | 1.26× | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $52.0M |
| Free Cash FlowOCF − Capex | — | $13.0M |
| FCF MarginFCF / Revenue | — | 1.6% |
| Capex IntensityCapex / Revenue | — | 4.9% |
| Cash ConversionOCF / Net Profit | — | 0.63× |
| TTM Free Cash FlowTrailing 4 quarters | — | $104.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $52.0M | ||
| Q3 25 | $659.9M | $71.0M | ||
| Q2 25 | $303.0M | $57.0M | ||
| Q1 25 | $183.8M | $53.0M | ||
| Q4 24 | $301.4M | $65.0M | ||
| Q3 24 | $199.5M | $85.0M | ||
| Q2 24 | $279.4M | $73.0M |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $13.0M | ||
| Q3 25 | $579.4M | $38.0M | ||
| Q2 25 | $208.9M | $27.0M | ||
| Q1 25 | $96.8M | $26.0M | ||
| Q4 24 | $176.8M | $33.0M | ||
| Q3 24 | $88.3M | $59.0M | ||
| Q2 24 | $213.3M | $49.0M |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 1.6% | ||
| Q3 25 | 47.9% | 5.6% | ||
| Q2 25 | 18.1% | 4.3% | ||
| Q1 25 | 9.3% | 4.2% | ||
| Q4 24 | 15.9% | 5.6% | ||
| Q3 24 | 8.9% | 9.9% | ||
| Q2 24 | 21.2% | 7.8% |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 4.9% | ||
| Q3 25 | 6.7% | 4.9% | ||
| Q2 25 | 8.1% | 4.8% | ||
| Q1 25 | 8.4% | 4.3% | ||
| Q4 24 | 11.2% | 5.4% | ||
| Q3 24 | 11.2% | 4.4% | ||
| Q2 24 | 6.6% | 3.8% |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 0.63× | ||
| Q3 25 | 2.33× | — | ||
| Q2 25 | 1.69× | 3.80× | ||
| Q1 25 | 1.74× | 0.71× | ||
| Q4 24 | 1.99× | — | ||
| Q3 24 | 1.48× | — | ||
| Q2 24 | 1.95× | 2.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DXCM
Segment breakdown not available.
GBTG
| Travel | $620.0M | 78% |
| Other | $172.0M | 22% |
